- About Us
- Executive Committee
- Committees and Trustees
- Company Papers
- Your Privacy
- Regional Leads
- Respiratory Clinical Leadership Programme
- Affiliated Groups
- Your questions answered
- Respiratory Researchers
- Annual Conference
- Respiratory Clinical Leadership Programme
- Local Group Leaders Events
- Researchers Meeting
- Professional Development
- Primary Care Respiratory Update
- Resources for patients and carers
- Contact Us
Confirmed Conference Exhibitors
Action for Pulmonary Fibrosis was set up by patients, their families and clinical researchers to support people living with Idiopathic Pulmonary Fibrosis (IPF) and other forms of the disease. Our vision is a world in which everyone living with pulmonary fibrosis has a better future. We provide support through patient support groups across the UK and our patent support line; we educate nurses and other health care professionals about the disease; we campaign to improve patient care and we invest in research to develop better treatments for the disease. Please visit www.actionpulmonaryfibrosis.org for more information.
Established in 2009, and with a product portfolio encompassing generic and branded pharmaceuticals, medical devices and diagnostics, Aspire Pharma is a rapidly growing UK pharmaceutical company that continues to exceed expectations. While providing significant economic savings for the NHS and sustainable value for both customers and partners alike, the company prides itself on delivering innovation that translates in to real world benefits for patients in the UK.
The ARTP is the sole professional organisation in the UK for practitioners working in respiratory & sleep physiology. ARTP provides nationally, professionally recognised qualifications in lung function testing/spirometry. An important function of the ARTP is the provision for CPD and the writing of standards/guidelines. ARTP organises an Annual Conference and training courses including blood gas sampling, interpretation, respiratory muscle assessment, sleep disorders and cardiopulmonary exercise testing. ARTP coordinates spirometry training centres throughout the UK and also write/publish textbooks in lung function testing and physiology. ARTP Sleep represents practitioners working in Sleep Medicine. Further details are available from www.artp.org.uk or email email@example.com or Telephone 01543 442141.
The Association of Chartered Physiotherapists in Respiratory Care is a National Body which promotes health and best practice in Respiratory Physiotherapy for the benefit of all. The ACPRC was originally established in 1980, and with over 1,000 members is one of the largest professional networks of physiotherapists in the UK . Each year, the ACPRC publish the only journal dedicated to Respiratory Physiotherapy, a Respiratory Review and a monthly e-Newsletter with all of the latest updates in Respiratory Care. The committee also deliver a wide range of short courses, a bi-annual conference and support members with a wide range of general enquiries. Since 2016, the four core pillars of the ACPRC have been: Connecting People Sharing Knowledge and Skills Research and Best Practice Leadership and Innovation The ACPRC is run by an elected commiittee of members who support the organisation on a voluntary basis. The committee itself is made up of a wide range of specialist physiotherapists, many of whom are leading figures in their area of expertise.
ARNS was created in 1997 by respiratory nurses, for respiratory nurses, and this ethos is still very true today as we celebrated our 20th year in 2017. ARNS remains the only nursing-led membership organisation within the UK respiratory specialty field. Today, our organisation benefits from the participation of more than 1,500 members across the UK ARNS collaborates with other respiratory care organisations, as well as government and NHS initiatives in order to influence policy and developments for respiratory services, such as the NICE and BTS Guidelines. ARNS is a member of the European Respiratory Nurses Association. Secretariat Office: 10 Hartley Close, Stoke Poges, Bucks, SL3 6NS Email: firstname.lastname@example.org Phone: 07740117902 Website: www.arns.co.uk Twitter: @ARNS_UK
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit www.astrazeneca.com
Atlantic Pharma is a family owned UK business. We are dedicated to bringing high quality cost-effective medicines to the NHS. Our products are manufactured in Switzerland, ensuring the highest quality and available from all UK wholesalers, ensuring robust supply. We pride ourselves on finding product solutions that can give real world benefits to patients at an affordable cost to the NHS.
Boehringer Ingelheim For more than 130 years, our research-driven pharmaceutical company has created innovative medicines for people and animals. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Every day, our 50,000 employees create value through innovation in our three business areas: human pharmaceuticals, animal health and biopharmaceutical contract manufacturing Social responsibility comes naturally to Boehringer Ingelheim. That’s why we are involved in social projects such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from our employees’ different experiences and skills. Environmental protection and sustainability is the focus of everything we do. More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.
One in five of us has problems with our breathing. Millions more are at risk. We’re the only UK charity looking after the nation’s lungs. With your support, we’ll make sure that one day everyone breathes clean air with healthy lungs. For further information, please visit www.blf.org.uk. For help and support, call the BLF Helpline on 03000 030 555. To donate £5 to help the BLF fight lung disease, please text LUNGS to 70500.
Captium Limited is a distributor focused in respiratory and working with companies including Lofarma (tablet immunotherapy and skin prick tests) and Hitachi (allergy diagnosis). We will soon be launching the Smart Peak Flow meter for use in asthma (www.smartpeakflow.com). The Smart Peak Flow meter is a small electronic device that plugs into any smart phone and allows for the easy recording and sharing of results.
Chiesi Limited is the UK affiliate of Chiesi Farmaceutici S.p.A. It is headquartered in Manchester and employs over 250 employees. Chiesi Farmaceutici is an international research-focussed Healthcare Group based in Parma, Italy, with over 80 years of experience in the pharmaceutical industry. The group employs nearly 5,000 people and has affiliates in 26 countries, with its products reaching over 70 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organisation is also headquartered in Parma, Italy, and integrated with six other key R&D groups in France, the USA, the UK, Sweden and Denmark to advance Chiesi's pre-clinical, clinical and registration programmes. R&D remains a key priority for Chiesi, with the product pipeline increasingly leveraging novel, proprietary therapeutics that target diseases with high unmet medical need, with the ultimate aim of giving patients access to innovative medicines that improve quality of life.
Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last 8 decades, we have strengthened our leadership in India’s pharmaceutical industry and fortified our promise of ‘Caring for Life’. We are now strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the UK, the US, and other economies of the emerging world
Circassia is a specialty pharmaceutical company focused on respiratory disease. Our market-leading NIOX® products are used by specialists around the world to measure airway inflammation at the point of care and aid asthma diagnosis and management.
Respiratory specialists Clement Clarke International, have a series of innovative devices to showcase at the PCRS meeting. Visit us to see how we can enhance our Flo-Tone inhaler guidance mouthpiece using mobile Apps to make ensure correct use of inhaler devices. See also the latest on our Able, A2A and DispozABLE Spacers and our In-Check DIAL G16.
"Working Together to Improve Lives by Inspiring Excellence in Home Healthcare” Dolby Vivisol is a unique UK provider of Home Healthcare services specialising in respiratory care. We offer a range of services including home oxygen therapy; of which we currently hold three of the NHS regional contracts for providing this service to around 20,000 patients, 24 hours a day 7 days a week. Other services include home NIV services; diagnosis and treatment of sleep disordered breathing, aerosol and nebuliser therapy. We have over 28 years' experience throughout the UK and Europe, supporting research and development to provide benefits to our patients, from the flexibility built into our systems to the adoption of new technology, we deliver a high quality of care. We constantly look to adopt innovation and improve our products and services through extensive research and engaging with Healthcare Professionals and patients. By bringing our vision to life, we seek to help create the most beneficial care environment within the patient's home, thus enabling them to follow their prescribed treatment, achieve the best possible outcome, and improve their quality of life. Come and visit us on stand 33 www.dolbyvivisol.com
Improving the lives of people living with long term conditions - Education for Health is a leading UK based educational charity, supporting nurses and healthcare professionals working with patients living with long term conditions. Through our clinically led education and training, research and advocacy work, we are playing an integral role in enabling healthcare professionals to deliver the best possible care for patients. We offer a comprehensive range of education and training, including free-to-access online resources, workshops and accredited Level 5, 6 and 7 modules which can be taken as standalone courses or used to achieve a full DipHE, BSc or MSc degree programme. Our academic team are clinicians and experts in their subject areas who continue to work in practice, bringing a real-life vibrancy to all that we do. Innovative teaching techniques and learning materials enable students to combine work and professional development. Website: www.educationforhealth.org Email: email@example.com Twitter: @EdforHealth Facebook: www.facebook.com/EdforHealth/
GSK is a science-led global healthcare company with a mission to help people do more, feel better and live longer. For more than 45 years, GSK has been a leader in respiratory, helping patients with respiratory disease better manage their condition. Working in collaboration with the scientific community, we remain at the cutting-edge of scientific research into innovative medicines with the aim of helping to treat patients’ symptoms and reduce the risk of their disease. For further information please visit www.gsk.com.
The ILD Interdisciplinary Network (ILD-INN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INNs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
Intermedical Cardio Respiratory is a leading specialist provider of cardio-respiratory diagnostic devices and therapy products. This year, we will be demonstrating the Bedfont NObreath monitor and performing FeNO testing on the stand. This portable device measures FeNO in a single breath sample and facilitates better management of Asthma in patients. We will also be showcasing our Spirometer range including the popular MIR Spirolab; a desktop Spirometer featuring a 7” touchscreen display, which has been developed and designed especially for respiratory healthcare professionals in the UK.
MDUK is focused on high quality products that improve respiratory care. These include space chambers for the delivery of asthma and COPD medication, portable low-power consumption nebulisers and finger type pulse oximeters measuring SpO2. We have resently launched the Anti-Satic Space Chamber Plus Compact and Standard size Spacers for use with PMDIs. They are on perscription throughout the UK. The company’s products are available from most high street pharmacy chains.
As the UK's leading medical supplies company, Williams provide a full 'end to end' service which combines the market's best prices with an extensive range of value-added benefits. Supported by CareFusion, Williams is the approved Primary Care supplier of Micro Medical Spirometers and CO Monitors, including the Gold Standard MicroLab and MicroLoop. • Technical support and advice for practitioners completing their ARTP/BTS accreditation • Conforms with ‘A guide to Performing Quality Assured Diagnostic Spirometry’ • GLI (Global Lung Initiative) predicted values, automatic interpretation and reproducibility guidance • FREE software updates • Software exports results directly to SystmOne and EMIS Visit the Micro Medical at Williams Medical stand today to benefit from… • FREE technical support and advice; ideal for practitioners completing their ARTP/BTS accreditation • FREE product demos • Exclusive discounts • Value-added takeaways, including FREE spirometer calibration logbooks
Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We are a committed long-term NHS provider in respiratory medicine, supporting the delivery of real-world evidence and education. We aim to provide high-quality asthma medicines that meet genuine needs, make a positive difference to patients’ lives and offer value to the NHS.
The National Asthma and COPD Audit Programme (NACAP) for England, Scotland and Wales aims to improve the quality of care, services and clinical outcomes for patients with asthma (adult and paediatric) and chronic obstructive pulmonary disease (COPD). Spanning the entire patient care pathway, NACAP will include strong collaboration with asthma and COPD patients, as well as healthcare professionals, and aspires to set out a vision for a service which puts patient needs first. The programme comprises a primary care audit in Wales for patients with asthma (both paediatric and adult) and COPD, as well as workstreams spanning secondary care, pulmonary rehabilitation and quality improvement. For further information about the primary care audit in Wales please visit www.rcplondon.ac.uk/nacap-primary-care. You can find the most recent primary care audit report for COPD, under the previous National COPD Audit Programme, at: www.rcplondon.ac.uk/nacap-primary-care. For information about the wider programme please visit www.rcplondon.ac.uk/nacap. You can also contact us at firstname.lastname@example.org or 020 3075 1526.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. Novartis Group companies employ approximately 119,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. For more information, please visit http://www.novartis.co.uk
SpiroConnect is the new and improved turbine spirometer designed by Chris Lawson, Micro Medical’s Technical Director for 27 years and creator of the MicroLab, MicroLoop and SpiroUSB spirometers. With its patented vertical turbine, SpiroConnect is more sensitive to low respiratory flow rates and therefore perfect for testing COPD and Asthma patients. SpiroConnect is also the most comprehensively integrated with the EMIS, SystmOne and Vision GP clinical systems, filing up to 40 user selectable Read codes and a PDF spirometry report in seconds at the end of the test. SpiroConnect is safer, easier, faster and more accurate. Please visit the Numed stand or website, or call us to find out more. www.numed.co.uk 0114 2433896
We believe in the power of nutrition at the heart of health and healthcare. We create advanced medical nutrition for our consumers, patients and those who care for them.
Orion Pharma (UK) Ltd. is a subsidiary of Orion Corporation, a pharmaceutical company based in Finland. Orion carries out extensive research with a goal of introducing new treatments into global markets. Core therapy areas in Orion’s product and research strategy are Respiratory, Critical Care, CNS, Women’s Health and oncology.
PARI develop solutions for people suffering from respiratory diseases in the form of high-quality, reliable devices and has been a leading manufacturer within the respiratory field for well over 100 years. PARI has recently introduced a new range of diagnostic devices – consisting of the PARI SpiroSense® spirometry solution and the Bosch Vivatmo FeNO testing solution. The SpiroSense solution comprises an easy-to-use PC spirometer for healthcare professionals, with the option of adding a mobile handheld device for patients to use at home. SpiroSense automatically self-calibrates, removing the need for time-consuming calibration and servicing. The Vivatmo FeNO testing solution offers a simple, maintenance-free option that can be added to the patient pathway. Intuitive user guidance and visual animation enables easy measurements. This year PARI is also celebrating 50 Years of the PARI BOY nebuliser brand with a charity campaign – it is completely free to enter and all money raised will be donated to the British Lung Foundation. For further information visit the PARI stand. PARI Medical Ltd The Old Sorting Office Rosemount Avenue West Byfleet Surrey KT14 6LB Tel: 01932 341122 Fax: 01932 341134 www.pari.com email: email@example.com
Pfizer applies science and global resources to bring therapies to people that extend and significantly improve their lives. Pfizer colleagues strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. The Pfizer global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with the organisation’s responsibility as one of the world's premier innovative biopharmaceutical companies, Pfizer collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about Pfizer’s commitments, please visit www.pfizer.co.uk. PP-CHM-GBR-1400 | January 2018
Philips, a global leader in the sleep and respiratory markets, is passionate about improving the quality of people’s lives with solutions that are designed around the needs of our customers and their patients. For Philips, innovation is driven by gaining insight into the needs of the people who use our products in the areas of sleep management, oxygen therapy, noninvasive ventilation and respiratory drug delivery. This tradition of innovation combined with our ability to anticipate market needs has made Philips a name acknowledged worldwide as a pace-setter in the markets we serve.
Set up in 2016, the Primary Care Respiratory Academy has been developed in partnership with the Primary Care Respiratory Society UK and is partnered with Cogora’s market-leading media brands Pulse, Nursing in Practice, Management in Practice and Healthcare Leader. It consists of two Platforms – Clinical (for GPs, nurses and practice pharmacists) and Commissioning (for experts involved in improving population-level respiratory health outcomes). The Clinical Platform has been bringing best-practice respiratory education to UK primary care professionals since 2016, comprising live Roadshow events, Digital Resources, CPD Modules, a monthly Journal Club and a monthly Newsletter. This year, it delivered an expert-led programme of 20 live events covering practical essentials in respiratory care, guidance updates and interactive workshops, where expertise from the audiences was aired and shared. The Commissioning Platform, launched in 2017, includes live workshops, Digital Resources and a monthly Newsletter. This year’s live workshops attracted an audience including respiratory commissioning leads, long-term commissioning leads, service transformation leads and medicines optimisation leads – representing 54 Clinical Commissioning Groups across England. Led by a team of enthusiastic commissioning professionals, the delegates had the time and space to focus on what was important to them and their local issues.
Queen Mary is a global leading university enhancing the regional, national and international agenda. We have a unique student, research and public engagement profile compared to any other university, pushing the boundaries of research and innovation and providing opportunities to individuals with talent and potential, irrespective of their background.
Respiratory Matters Ltd was founded in 2011 and offers training and education, mentorship, and project management, to support individuals, clinical commissioning groups and private companies to improve the care and outcomes of people with respiratory disease. We achieved the Clinical Skills & simulation Quality Assurance standards certificate from NHS Health Education Yorkshire and Humber in 2016. Education We deliver accredited foundation, interpretation and full spirometry certificate courses, Asthma and COPD diplomas and certificate courses, and bespoke respiratory education. We will deliver education anywhere in the country. We also lecture at Keele and Huddersfield Universities. Projects We are regularly commissioned by CCG’s for project management and education. • 2011. Yorkshire and Humber SHA and Asthma UK. First Paediatric Asthma Local Enhanced Service in the UK. Clinical Lead • 2012-2014. Calderdale CCG Living Well with asthma project (Paediatrics). Clinical Lead • 2015. Calderdale. Provision of COPD and spirometry education and project support for COPD case finding project. Education Lead • 2015 –2016 Leeds West CCG. Paediatric Asthma Project. Clinical Lead • 2017-2018. North Lancs, Blackburn and Darwen CCG. Delivery of accredited spirometry courses • 2018. Sheffield CCG. Delivery of accredited spirometry, asthma and COPD courses • 2018 Salford CCG, digital health innovation. Paediatric asthma. Project lead
SarcoidosisUK was founded in 1997 and has been helping people with sarcoidosis ever since. All members of the Board have personal experience of sarcoidosis. SarcoidosisUK is a charity funded solely from personal donations – of both time and money. Sarcoidosis is a rare disease and suffers from poor quality information, low levels of support and almost no research into finding a cure. SarcoidosisUK works to change that. Information and support is mostly done by volunteers allowing us to put the vast majority of funds into research. SarcoidosisUK has four goals: Information: Providing accurate and detailed information to people with sarcoidosis, their carers, and medical professionals. Support: We provide emotional support for people with sarcoidosis and their carers by telephone, email, via social media and at our support groups across the UK. Finding a cure: SarcoidosisUK raises funds and invests them into focused medical research that works directly to finding a cure for sarcoidosis. Awareness: We recognise the lack of understanding and awareness from both the medical profession and the general public regarding sarcoidosis. We aim to change this.
Slater and Gordon is one of the UK’s leading consumer law firms. Our goal is to deliver exceptional, world class legal services in all aspects of injury and negligence, with offices throughout the UK. Slater and Gordon has a team of experts who specialise in asbestos related disease and can provide your patients with all the necessary advice to pursue a claim for compensation.
npj Primary Care Respiratory Medicine is published in partnership between Primary Care Respiratory Society UK and Springer Nature. Authors whose papers are accepted for publication within npj Primary Care Respiratory Medicine are required to pay an article processing charge (APC). All members of PCRS-UK are entitled to a discounted APC (50% reduction on the full rate) if an article for which they are the corresponding author is accepted for publication within the journal. The discounted rate is also available to anyone who has presented an abstract or poster at a PCRS-UK conference within the previous year.
At The Institute of Clinical Science and Technology, we are the innovators of blended flexible medical training and learning. We run and manage a growing range spectrum of accredited educational programmes and QI (quality improvement) programmes.
As the ImmunoDiagnostic experts within Thermo Fisher Scientific, we develop manufacture and market complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.
Trudell Medical UK Limited (TM-UK) TM-UK is committed to enhancing the quality of life for people of all ages with respiratory conditions. We are part of Trudell Medical International, a family owned healthcare company that designs, develops and manufactures a wide range of high quality, innovative medical devices and is home to a global Aerosol Lab and Research Centre. New AeroChamber Plus* Flow-Vu* Anti-Static Valved Holding Chamber (VHC) and our award-winning Aerobika* OPEP device, are now available on prescription in the UK. Come and see us to find out more.
For over 50 years Vitalograph has provided world-leading respiratory screening, diagnostic and monitoring devices. Since the early days of the wedge bellows through to the sophisticated computerised systems we offer today Vitalograph continue to push back the boundaries of possibility in Primary Care. Vitalograph spirometers are the natural choice for high performance, optimal hygiene and low running costs. Visit our stand to take a look at our extensive range of handheld, PC-based and desktop spirometers. In addition to the In2itive, Pneumotrac, ALPHA Touch spirometers we offer a wide range of affordable, easy-to-use respiratory monitors and screeners. Our Vitalink connectivity software provides an automatic two-way interface with your practice software (including EMIS, SystmOne and Vision). We also offer great value consumables such as the new Eco BVF range of 100% recyclable filters that provide protection for patients, medical personnel and equipment (99.999% filtration efficiency).